View the EFIME-200 registration information details.
Back to drug list
ItemsDrug Registration information
ID2184
No2184
Brand NameEFIME-200
IngredientsCEFIXIME TRIHYDRATE EQ.TO CEFIXIME ANHYDROUS 200 MG
Dosage Form DISPERSIBLE TABLET
Primary PackagingALU-ALU BLISTER
Storage
Shelf Life36 MONTHS
Pack SizeBOX OF 2 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF BACTERIAL INFECTIONS WHEN CAUSED BY SUSCEPTIBLE ORGANISMS: UPPER AND LOWER RESPIRATORY TRACT INFECTION (OTITIS MEDIA, BRONCHITIS), URINARY TRACT INFECTION (CYSTITIS, CYSTOURETHRITIS, UNCOMPLICATED PYELONEPHRITIS).
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE TO OFF WHITE COLOURED, ROUND, STANDARD BICONVEX, UNCOATED DISPERSIBLE TABLET WITH BREAK LINE ON ONE SIDE AND PLAIN ON OTHER SIDE
Note
License OwnerPOUNSAB PHARMA CO.,LTD
ManufacturerBAROQUE PHARMACEUTICALS PVT LTD.
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No02 I 4020/15
FDD Registration Date07/07/2025
Expiry Date06/07/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA